Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited-stage small-cell lung cancer

MLA

Meng Lu, et al. “Pathologic Responses to Neoadjuvant Chemoimmunotherapy in Primary Limited-Stage Small-Cell Lung Cancer.” Thoracic Cancer, vol. 13, no. 22, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b69583ceedce301dde1b5ca53cd846ea&authtype=sso&custid=ns315887.

APA

Meng Lu, Ran Zhang, Li‐sha Qi, Ya‐lei Wang, Xiao‐xuan Sun, & Jian You. (2022). Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited-stage small-cell lung cancer. Thoracic Cancer, 13(22).

Chicago

Meng Lu, Ran Zhang, Li‐sha Qi, Ya‐lei Wang, Xiao‐xuan Sun, and Jian You. 2022. “Pathologic Responses to Neoadjuvant Chemoimmunotherapy in Primary Limited-Stage Small-Cell Lung Cancer.” Thoracic Cancer 13 (22). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b69583ceedce301dde1b5ca53cd846ea&authtype=sso&custid=ns315887.